These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 509335)
1. [Prevention of bacterial respiratory infections by ribosomal vaccines]. Michel FB; D'Hinterland LD; Fumex JP; Guendon R Bronchopneumologie; 1979; 29(4):337-42. PubMed ID: 509335 [No Abstract] [Full Text] [Related]
2. [Immunomodulatory properties of ribosomal vaccine in the prevention of recurrent infections]. Gawlik R; Danek K Przegl Lek; 2002; 59(6):450-2. PubMed ID: 12418285 [TBL] [Abstract][Full Text] [Related]
3. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology. Charachon R; Lavillauroy PJ; Fumex JP Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781 [No Abstract] [Full Text] [Related]
4. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study. Fumex JP; Michel FB Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376 [No Abstract] [Full Text] [Related]
5. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks. Michel FB; Dussourd d'Hinterland L Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779 [No Abstract] [Full Text] [Related]
6. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation. Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780 [TBL] [Abstract][Full Text] [Related]
7. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections]. Luther P; Brachmann I; Werchan D; Wittig C; Tischner H Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367 [TBL] [Abstract][Full Text] [Related]
8. Prevention of infections of the respiratory tract using the oral application of antigens. Tischner H Z Erkr Atmungsorgane; 1991; 176(2-3):131-7. PubMed ID: 1858413 [No Abstract] [Full Text] [Related]
10. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Oliveira ML; Arêas AP; Ho PL Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756 [TBL] [Abstract][Full Text] [Related]
11. [Anticatarrh vaccine--to what use?]. Heller L Lakartidningen; 1976 May; 73(21):2007-8. PubMed ID: 1271937 [No Abstract] [Full Text] [Related]
12. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months]. Debelic M; Eckenberger HP Fortschr Med; 1992 Nov; 110(30):565-70. PubMed ID: 1468743 [TBL] [Abstract][Full Text] [Related]
13. Vaccinology in the prophylaxis of respiratory infections--Part II. Griffin JP Clin Notes Respir Dis; 1978; 17(2):3-12. PubMed ID: 699411 [No Abstract] [Full Text] [Related]
14. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study. Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117 [TBL] [Abstract][Full Text] [Related]
16. Role of bacterial vaccines in prevention of respiratory infections with special reference to pneumococcal vaccines. Huchon G Postgrad Med J; 1983; 59 Suppl 3():185-7. PubMed ID: 6647205 [TBL] [Abstract][Full Text] [Related]
17. [Immunization in pneumology]. Schaberg T; Lode H Pneumologie; 1994 Aug; 48(8):505-10. PubMed ID: 7971886 [No Abstract] [Full Text] [Related]
19. [Pleuromyopericarditis as a result of hyperimmunization with anticatarrh vaccine]. Bloth B; Lundman T Lakartidningen; 1976 May; 73(21):2026-8. PubMed ID: 1271943 [No Abstract] [Full Text] [Related]